Page 263 - Small Animal Internal Medicine, 6th Edition
P. 263

CHAPTER 12   Thromboembolic Disease   235


            Thompson MF, Scott-Moncrieff JC, Hogan DF. Thrombolytic   Welch KM, et al. Prospective evaluation of tissue plasminogen acti-
              therapy in dogs and cats. J Vet Emerg Crit Care (San Antonio).   vator in 11 cats with arterial thromboembolism.  J  Feline  Med
  VetBooks.ir  Van De Wiele CM, et al. Antithrombotic effect of enoxaparin in   Williams TPE, et al. Aortic thrombosis in dogs. J Vet Emerg Crit
              2001;11:111–121.
                                                                  Surg. 2010;12:122–128.
              clinically healthy cats: a venous stasis model. J Vet Intern Med.
                                                                  Care (San Antonio). 2017;27:9–22.
              2010;24:185–191.                                   Winter RL, et al. Aortic thrombosis in dogs: presentation, therapy,
            Van Winkle TJ, Hackner SG, Liu SM. Clinical and pathological   and outcome in 26 cases. J Vet Cardiol. 2012;14:333–342.
              features of aortic thromboembolism in 36 dogs. J Vet Emerg Crit   Yang VK, et al. The use of rivaroxaban for the treatment of throm-
              Care (San Antonio). 1993;3:13–21.                   botic complications in four dogs.  J Vet Emerg Crit Care (San
            Weinkle TK, et al. Evaluation of prognostic factors, survival rates,   Antonio). 2016;26:729–736.
              and treatment protocols for immune-mediated hemolytic anemia
              in dogs: 151 cases (1993-2002). J Am Vet Med Assoc. 2005;226:
              1869–1880.







            Drugs Used in Cardiovascular Disorders

                               TRADE
             GENERIC NAME      NAME        DOG                                 CAT

             Diuretics
             Furosemide        Lasix       Chronic therapy: 1-3 (or more) mg/kg   Chronic therapy: 1-2 (or more) mg/kg
                               Salix         q8-24h PO (use lowest effective dose;   q8-24h PO (use lowest effective dose;
                                             maximum daily dose ~10[-12] mg/kg/  maximum daily dose ~8 mg/kg/day,
                                             day, depending on renal function).  depending on renal function).
                                           Acute: 2(-4+) mg/kg initial bolus, then   Acute: 1-2 mg/kg initial bolus, then
                                             1-4 mg/kg q1-4h until RR decreases,   1-2 mg/kg q1-4h until RR decreases,
                                             then 1-4 mg/kg q6-12h IV, IM, SC; or   then 1-2 mg/kg q6-12h IV, IM, SC;
                                             follow IV bolus with 0.6-1 mg/kg/h CRI   or follow IV bolus with 0.3-0.6 mg/
                                             until RR decreases (see Chapter 3)  kg/h CRI until RR decreases (see
                                                                                 Chapter 3)
             Torsemide         Demadex      1 10  ( 12 - 8 ) of total daily furosemide dose,   ~ 10  of total daily furosemide dose,
                                                                                 1
                                                  1
                                               1
                                             divide q12h (in place of furosemide)  divide q12h (in place of furosemide)
             Spironolactone    Aldactone   2 mg/kg PO q24h (or divided q12h); can  1-2 mg/kg PO q24h (or divided q12h);
                                             start lower                         can start lower
             Chlorothiazide    Diuril      10-40 mg/kg PO q12-48h (start qod with   10-40 mg/kg PO q12-48h (start qod
                                             low dose)                           with low dose)
             Hydrochlorothiazide  Hydrodiuril  0.5-4 mg/kg PO q12-48h (start qod with   0.5-2 mg/kg PO q12-48h (start qod
                                             low dose)                           with low dose)
             Angiotensin-Converting Enzyme Inhibitors
             Enalapril         Enacard     0.5 mg/kg PO q12(-24)h              0.25-0.5 mg/kg PO q24h
                               Vasotec
             Benazepril        Lotensin    0.25-0.5 mg/kg PO q12(-24)h         0.25-0.5 mg/kg PO q24h
             Captopril         Capoten     0.5-2 mg/kg PO q8-12h               0.5-1.25 mg/kg PO q(8-)24h
             Lisinopril        Prinivil    0.25-0.5 mg/kg PO q(12-)24h         0.25-0.5 mg/kg PO q24h
                               Zestril
             Ramipril          Altace      0.125-0.25 mg/kg PO q24h            0.125 mg/kg PO q24h
             Angiotensin-Receptor Blockers
             Telmisartan       Micardis    1 mg/kg PO q24h                     (1-)2 mg/kg PO q24h
                               Semintra
             Irbesartan        Avapro      –                                   10 mg/kg PO q24h (experimental)
                                                                                                          Continued
   258   259   260   261   262   263   264   265   266   267   268